Norway Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $461K | Sell |
7,993
-53
| -0.7% | -$3.04K | 0.19% | 82 |
|
|
2026
Q1 | $488K | Sell |
8,046
-140
| -2% | -$8.16K | 0.23% | 81 |
|
|
2025
Q4 | $442K | Buy |
8,186
+3
| +0% | +$144 | 0.2% | 82 |
|
|
2025
Q3 | $369K | Sell |
8,183
-65
| -0.8% | -$3.04K | 0.18% | 86 |
|
|
2025
Q2 | $382K | Sell |
8,248
-430
| -5% | -$21.1K | 0.2% | 85 |
|
|
2025
Q1 | $529K | Sell |
8,678
-235
| -3% | -$13.7K | 0.3% | 75 |
|
|
2024
Q4 | $504K | Sell |
8,913
-200
| -2% | -$11.2K | 0.28% | 80 |
|
|
2024
Q3 | $472K | Sell |
9,113
-1,040
| -10% | -$48.8K | 0.26% | 80 |
|
|
2024
Q2 | $422K | Sell |
10,153
-435
| -4% | -$19.5K | 0.24% | 82 |
|
|
2024
Q1 | $574K | Sell |
10,588
-115
| -1% | -$5.86K | 0.24% | 103 |
|
|
2023
Q4 | $549K | Sell |
10,703
-45
| -0.4% | -$2.36K | 0.24% | 104 |
|
|
2023
Q3 | $624K | Sell |
10,748
-442
| -4% | -$27.1K | 0.31% | 95 |
|
|
2023
Q2 | $716K | Buy |
11,190
+1,200
| +12% | +$80.5K | 0.39% | 79 |
|
|
2023
Q1 | $692K | Buy |
9,990
+1,040
| +12% | +$73.4K | 0.35% | 86 |
|
|
2022
Q4 | $644K | Buy |
8,950
+42
| +0.5% | +$3.17K | 0.33% | 87 |
|
|
2022
Q3 | $634K | Hold |
8,908
| – | – | 0.35% | 85 |
|
|
2022
Q2 | $686K | Sell |
8,908
-39
| -0.4% | -$2.97K | 0.36% | 81 |
|
|
2022
Q1 | $654K | Hold |
8,947
| – | – | 0.3% | 89 |
|
|
2021
Q4 | $557K | Hold |
8,947
| – | – | 0.24% | 99 |
|
|
2021
Q3 | $530K | Buy |
8,947
+60
| +0.7% | +$3.95K | 0.25% | 96 |
|
|
2021
Q2 | $594K | Hold |
8,887
| – | – | 0.29% | 87 |
|
|
2021
Q1 | $561K | Hold |
8,887
| – | – | 0.3% | 84 |
|
|
2020
Q4 | $551K | Hold |
8,887
| – | – | 0.32% | 80 |
|
|
2020
Q3 | $536K | Hold |
8,887
| – | – | 0.36% | 76 |
|
|
2020
Q2 | $522K | Hold |
8,887
| – | – | 0.38% | 71 |
|
|
2020
Q1 | $495K | Sell |
8,887
-45
| -0.5% | -$2.75K | 0.43% | 67 |
|
|
2019
Q4 | $574K | Buy |
8,932
+6,489
| +266% | +$372K | 0.42% | 71 |
|
|
2019
Q3 | $123K | Hold |
2,443
| – | – | 0.1% | 119 |
|
|
2019
Q2 | $111K | Hold |
2,443
| – | – | 0.09% | 121 |
|
|
2019
Q1 | $117K | Hold |
2,443
| – | – | 0.1% | 118 |
|
|
2018
Q4 | $127K | Hold |
2,443
| – | – | 0.12% | 112 |
|
|
2018
Q3 | $151K | Sell |
2,443
-406
| -14% | -$24.1K | 0.13% | 107 |
|
|
2018
Q2 | $157K | Sell |
2,849
-1
| -0% | -$54 | 0.14% | 102 |
|
|
2018
Q1 | $180K | Sell |
2,850
-113
| -4% | -$7.27K | 0.17% | 97 |
|
|
2017
Q4 | $182K | Sell |
2,963
-559
| -16% | -$35K | 0.17% | 96 |
|
|
2017
Q3 | $224K | Hold |
3,522
| – | – | 0.21% | 87 |
|
|
2017
Q2 | $196K | Hold |
3,522
| – | – | 0.19% | 93 |
|
|
2017
Q1 | $192K | Hold |
3,522
| – | – | 0.2% | 89 |
|
|
2016
Q4 | $206K | Buy |
+3,522
| New | +$193K | 0.19% | 94 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Norway Savings Bank's BMY Position: Q2 2026 in Review
Norway Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.66% in Q2 2026, selling an estimated $3.04K and leaving 7,993 shares worth $461K. The position accounts for 0.19% of the portfolio, ranked #82.
Norway Savings Bank first reported a position in BMY in Q4 2016 and has held it in 39 quarters since. The position peaked at $716K in Q2 2023. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Norway Savings Bank held 7,993 shares of Bristol-Myers Squibb worth $461K as of Q2 2026.
- Norway Savings Bank sold 53 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.04K.
- Bristol-Myers Squibb made up 0.19% of Norway Savings Bank's portfolio in Q2 2026, its #82 holding.
- Norway Savings Bank first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 39 quarters since.
- Norway Savings Bank's Bristol-Myers Squibb position peaked at $716K in Q2 2023.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.